BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 199 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,148 | +0.6% | 162,084 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,141 | -14.8% | 162,084 | +0.9% | 0.00% | -33.3% |
| Q1 2023 | $1,339 | -24.6% | 160,599 | +3.8% | 0.00% | -25.0% |
| Q4 2022 | $1,775 | -99.9% | 154,699 | -7.7% | 0.00% | -20.0% |
| Q3 2022 | $2,110,000 | +19.2% | 167,530 | +0.1% | 0.01% | 0.0% |
| Q2 2022 | $1,770,000 | -37.2% | 167,360 | -3.4% | 0.01% | -16.7% |
| Q1 2022 | $2,817,000 | +19.1% | 173,292 | +1.5% | 0.01% | +20.0% |
| Q4 2021 | $2,365,000 | +36.9% | 170,807 | +42.1% | 0.01% | +25.0% |
| Q3 2021 | $1,727,000 | -9.5% | 120,223 | -0.5% | 0.00% | -20.0% |
| Q2 2021 | $1,909,000 | +52.1% | 120,799 | -2.2% | 0.01% | +25.0% |
| Q1 2021 | $1,255,000 | +42.3% | 123,459 | +4.2% | 0.00% | +33.3% |
| Q4 2020 | $882,000 | +114.6% | 118,455 | -1.2% | 0.00% | +200.0% |
| Q3 2020 | $411,000 | -23.3% | 119,896 | +6.6% | 0.00% | -50.0% |
| Q2 2020 | $536,000 | +169.3% | 112,496 | +12.9% | 0.00% | +100.0% |
| Q1 2020 | $199,000 | -31.8% | 99,612 | +17.6% | 0.00% | 0.0% |
| Q4 2019 | $292,000 | +77.0% | 84,680 | +46.7% | 0.00% | 0.0% |
| Q3 2019 | $165,000 | -17.9% | 57,730 | +8.5% | 0.00% | 0.0% |
| Q2 2019 | $201,000 | -42.9% | 53,230 | +22.8% | 0.00% | -50.0% |
| Q1 2019 | $352,000 | +0.9% | 43,330 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $349,000 | +5.8% | 43,330 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $330,000 | +33.1% | 43,330 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $248,000 | +19.8% | 43,330 | -0.5% | 0.00% | 0.0% |
| Q1 2018 | $207,000 | -1.9% | 43,530 | +1.4% | 0.00% | 0.0% |
| Q4 2017 | $211,000 | – | 42,930 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,637,700 | $77,675,000 | 7.44% |
| Burrage Capital Management LLC | 864,916 | $8,796,000 | 7.13% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,367,670 | $24,079,000 | 3.61% |
| HealthCor Management, L.P. | 4,886,440 | $49,695,000 | 1.76% |
| Ghost Tree Capital, LLC | 500,000 | $5,085,000 | 1.20% |
| Integral Health Asset Management, LLC | 400,000 | $4,068,000 | 1.16% |
| Lisanti Capital Growth, LLC | 472,520 | $4,806,000 | 0.62% |
| Parkman Healthcare Partners LLC | 244,680 | $2,488,000 | 0.58% |
| Baker Brothers Advisors | 12,710,818 | $129,269,000 | 0.56% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,605,380 | $26,497,000 | 0.56% |